Recombinant fviii formulations
AssigneeBayer HealthCare LLC
InventorsDeqian Wang, Xinghang Ma, Nelly Tsvetkova
Life of this patent
Estimating the term…
Abstract
Provided are liquid and lyophilized rFVIII formulations, including full-length rFVIII (FL-rFVIII) formulations, B-domain deleted rFVIII (BDD-rFVIII) formulations, and BDD-rFVIII mutant (BDD-rVIII mutant) formulations. Also provided are liquid and lyophilized PEGylated rFVIII (PEG-rFVIII) formulations, including PEGylated full-length rFVIII (PEG-FL-rFVIII) formulations, PEGylated B-domain deleted rFVIII (PEG-BDD-rFVIII) formulations, and PEGylated BDD-rFVIII mutant (PEG-BDD-rFVIII mutant) formulations.
Claims74
A full-length rFVIII (FL-rFVIII) formulation, comprising:
- a. from about 0 mM to about 20 mM or about 50 mM histidine;
- b. from about 0 mM to about 29 mM, or about 34 mM, or about 58 mM, or about 100 mM, or about 300 mM of a sugar or sugar alcohol;
- c. from about 1 mM to about 2 mM, or about 2.5 mM, or about 5 mM, or about 10 mM, or about 15 mM calcium chloride;
- d. from about 100 mM to about 150 mM, or about 200 mM, or about 220 mM, or about 250 mM sodium chloride;
- e. from about 20 ppm to about 50 ppm, or about 80 ppm, or about 100 ppm, or about 120 ppm, or about 200 ppm of a non-ionic surfactant;
- and
- f. from about 0.1 μg/ml to about 300 μg/ml, or from about 1.0 μg/ml to about 200 μg/ml, or from about 10 μg/ml to about 125 μg/ml of a FL-rFVIII;
- wherein said FL-rFVIII formulation has a pH from about pH 6.0 to about pH 6.5, or about pH 7.0, or about pH 7.5.
A B-domain deleted rFVIII (BDD-rFVIII) formulation, comprising:
- a. from about 0 mM to about 20 mM or about 50 mM histidine;
- b. from about 0 mM to about 29 mM, or about 34 mM, or about 58 mM, or about 100 mM, or about 300 mM of a sugar or sugar alcohol;
- c. from about 1 mM to about 2 mM, or about 2.5 mM, or about 5 mM, or about 10 mM, or about 15 mM calcium chloride;
- d. from about 100 mM to about 150 mM, or about 200 mM, or about 220 mM, or about 250 mM sodium chloride;
- e. from about 20 ppm to about 50 ppm, or about 80 ppm, or about 100 ppm, or about 120 ppm, or about 200 ppm of a non-ionic surfactant;
- and
- f. from about 0.1 μg/ml to about 300 μg/ml, or from about 1.0 μg/ml to about 200 μg/ml, or from about 10 μg/ml to about 125 μg/ml of a BDD-rFVIII;
- wherein said BDD-rFVIII formulation has a pH from about pH 6.0 to about pH 6.5, or about pH 7.0, or about pH 7.5.
A B-domain deleted rFVIII mutant (BDD-rFVIII-mutant) formulation, comprising:
- a. from about 0 mM to about 20 mM or about 50 mM histidine;
- b. from about 0 mM to about 29 mM, or about 34 mM, or about 58 mM, or about 100 mM, or about 300 mM of a sugar or sugar alcohol;
- c. from about 1 mM to about 2 mM, or about 2.5 mM, or about 5 mM, or about 10 mM, or about 15 mM calcium chloride;
- d. from about 100 mM to about 150 mM, or about 200 mM, or about 220 mM, or about 250 mM sodium chloride;
- e. from about 20 ppm to about 50 ppm, or about 80 ppm, or about 100 ppm, or about 120 ppm, or about 200 ppm of a non-ionic surfactant;
- and
- f. from about 0.1 μg/ml to about 300 μg/ml, or from about 1.0 μg/ml to about 200 μg/ml, or from about 10 μg/ml to about 125 μg/ml of a BDD-rFVIII-mutant;
- wherein said BDD-rFVIII-mutant formulation has a pH from about pH 6.0 to about pH 6.5, or about pH 7.0, or about pH 7.5.
A PEGylated full-length rFVIII (PEG FL-rFVIII) formulation, comprising:
- a. from about 0 mM to about 20 mM or about 50 mM histidine;
- b. from about 0 mM to about 29 mM, or about 34 mM, or about 58 mM, or about 100 mM, or about 300 mM of a sugar or sugar alcohol;
- c. from about 1 mM to about 2 mM, or about 2.5 mM, or about 5 mM, or about 10 mM, or about 15 mM calcium chloride;
- d. from about 100 mM to about 150 mM, or about 200 mM, or about 220 mM, or about 250 mM sodium chloride;
- e. from about 20 ppm to about 50 ppm, or about 80 ppm, or about 100 ppm, or about 120 ppm, or about 200 ppm of a non-ionic surfactant;
- and
- f. from about 0.1 μg/ml to about 300 μg/ml, or from about 1.0 μg/ml to about 200 μg/ml, or from about 10 μg/ml to about 125 μg/ml of a PEG FL-rFVIII;
- wherein said PEG FL-rFVIII formulation has a pH from about pH 6.0 to about pH 6.5, or about pH 7.0, or about pH 7.5.
A PEGylated B-domain deleted rFVIII (PEG-BDD-rFVIII) formulation, comprising:
- a. from about 0 mM to about 20 mM or about 50 mM histidine;
- b. from about 0 mM to about 29 mM, or about 34 mM, or about 58 mM, or about 100 mM, or about 300 mM of a sugar or sugar alcohol;
- c. from about 1 mM to about 2 mM, or about 2.5 mM, or about 5 mM, or about 10 mM, or about 15 mM calcium chloride;
- d. from about 100 mM to about 150 mM, or about 200 mM, or about 220 mM, or about 250 mM sodium chloride;
- e. from about 20 ppm to about 50 ppm, or about 80 ppm, or about 100 ppm, or about 120 ppm, or about 200 ppm of a non-ionic surfactant;
- and
- f. from about 0.1 μg/ml to about 300 μg/ml, or from about 1.0 μg/ml to about 200 μg/ml, or from about 10 μg/ml to about 125 μg/ml of a PEG-BDD-rFVIII;
- wherein said PEG-BDD-rFVIII formulation has a pH from about pH 6.0 to about pH 6.5, or about pH 7.0, or about pH 7.5.
A PEG BDD-rFVIII-mutant formulation, comprising:
- a. from about 0 mM to about 20 mM or about 50 mM histidine;
- b. from about 0 mM to about 29 mM, or about 34 mM, or about 58 mM, or about 100 mM, or about 300 mM of a sugar or sugar alcohol;
- c. from about 1 mM to about 2 mM, or about 2.5 mM, or about 5 mM, or about 10 mM, or about 15 mM calcium chloride;
- d. from about 100 mM to about 150 mM, or about 200 mM, or about 220 mM, or about 250 mM sodium chloride;
- e. from about 20 ppm to about 50 ppm, or about 80 ppm, or about 100 ppm, or about 120 ppm, or about 200 ppm of a non-ionic surfactant;
- and
- f. from about 0.1 μg/ml to about 300 μg/ml, or from about 1.0 μg/ml to about 200 μg/ml, or from about 10 μg/ml to about 125 μg/ml of a PEG BDD-rFVIII-mutant;
- wherein said PEG BDD-rFVIII-mutant formulation has a pH from about pH 6.0 to about pH 6.5, or about pH 7.0, or about pH 7.5.
A full-length rFVIII (FL-rFVIII) formulation, comprising:
- a. from about 0 mM to about 20 mM or about 50 mM MOPS;
- b. from about 0 mM to about 29 mM, or about 34 mM, or about 58 mM, or about 100 mM, or about 300 mM of a sugar or sugar alcohol;
- c. from about 1 mM to about 2 mM, or about 2.5 mM, or about 5 mM, or about 10 mM, or about 15 mM calcium chloride;
- d. from about 100 mM to about 150 mM, or about 200 mM, or about 220 mM, or about 250 mM sodium chloride;
- e. from about 20 ppm to about 50 ppm, or about 80 ppm, or about 100 ppm, or about 120 ppm, or about 200 ppm of a non-ionic surfactant;
- and
- f. from about 0.1 μg/ml to about 300 μg/ml, or from about 1.0 μg/ml to about 200 μg/ml, or from about 10 μg/ml to about 125 μg/ml of a FL-rFVIII;
- wherein said FL-rFVIII formulation has a pH from about pH 6.0 to about pH 6.5, or about pH 7.0, or about pH 7.5.
A B-domain deleted rFVIII (BDD-rFVIII) formulation, comprising:
- a. from about 0 mM to about 20 mM or about 50 mM MOPS;
- b. from about 0 mM to about 29 mM, or about 34 mM, or about 58 mM, or about 100 mM, or about 300 mM of a sugar or sugar alcohol;
- c. from about 1 mM to about 2 mM, or about 2.5 mM, or about 5 mM, or about 10 mM, or about 15 mM calcium chloride;
- d. from about 100 mM to about 150 mM, or about 200 mM, or about 220 mM, or about 250 mM sodium chloride;
- e. from about 20 ppm to about 50 ppm, or about 80 ppm, or about 100 ppm, or about 120 ppm, or about 200 ppm of a non-ionic surfactant;
- and
- f. from about 0.1 μg/ml to about 300 μg/ml, or from about 1.0 μg/ml to about 200 μg/ml, or from about 10 μg/ml to about 125 μg/ml of a BDD-rFVIII;
- wherein said BDD-rFVIII formulation has a pH from about pH 6.0 to about pH 6.5, or about pH 7.0, or about pH 7.5.
A B-domain deleted rFVIII mutant (BDD-rFVIII-mutant) formulation, comprising:
- a. from about 0 mM to about 20 mM or about 50 mM MOPS;
- b. from about 0 mM to about 29 mM, or about 34 mM, or about 58 mM, or about 100 mM, or about 300 mM of a sugar or sugar alcohol;
- c. from about 1 mM to about 2 mM, or about 2.5 mM, or about 5 mM, or about 10 mM, or about 15 mM calcium chloride;
- d. from about 100 mM to about 150 mM, or about 200 mM, or about 220 mM, or about 250 mM sodium chloride;
- e. from about 20 ppm to about 50 ppm, or about 80 ppm, or about 100 ppm, or about 120 ppm, or about 200 ppm of a non-ionic surfactant;
- and
- f. from about 0.1 μg/ml to about 300 μg/ml, or from about 1.0 μg/ml to about 200 μg/ml, or from about 10 μg/ml to about 125 μg/ml of a BDD-rFVIII-mutant;
- wherein said BDD-rFVIII-mutant formulation has a pH from about pH 6.0 to about pH 6.5, or about pH 7.0, or about pH 7.5.
A PEGylated full-length rFVIII (PEG FL-rFVIII) formulation, comprising:
- a. from about 0 mM to about 20 mM or about 50 mM MOPS;
- b. from about 0 mM to about 29 mM, or about 34 mM, or about 58 mM, or about 100 mM, or about 300 mM of a sugar or sugar alcohol;
- c. from about 1 mM to about 2 mM, or about 2.5 mM, or about 5 mM, or about 10 mM, or about 15 mM calcium chloride;
- d. from about 100 mM to about 150 mM, or about 200 mM, or about 220 mM, or about 250 mM sodium chloride;
- e. from about 20 ppm to about 50 ppm, or about 80 ppm, or about 100 ppm, or about 120 ppm, or about 200 ppm of a non-ionic surfactant;
- and
- f. from about 0.1 μg/ml to about 300 μg/ml, or from about 1.0 μg/ml to about 200 μg/ml, or from about 10 μg/ml to about 125 μg/ml of a PEG FL-rFVIII;
- wherein said PEG FL-rFVIII formulation has a pH from about pH 6.0 to about pH 6.5, or about pH 7.0, or about pH 7.5.
A PEGylated B-domain deleted rFVIII (PEG-BDD-rFVIII) formulation, comprising:
- a. from about 0 mM to about 20 mM or about 50 mM MOPS;
- b. from about 0 mM to about 29 mM, or about 34 mM, or about 58 mM, or about 100 mM, or about 300 mM of a sugar or sugar alcohol;
- c. from about 1 mM to about 2 mM, or about 2.5 mM, or about 5 mM, or about 10 mM, or about 15 mM calcium chloride;
- d. from about 100 mM to about 150 mM, or about 200 mM, or about 220 mM, or about 250 mM sodium chloride;
- e. from about 20 ppm to about 50 ppm, or about 80 ppm, or about 100 ppm, or about 120 ppm, or about 200 ppm of a non-ionic surfactant;
- and
- f. from about 0.1 μg/ml to about 300 μg/ml, or from about 1.0 μg/ml to about 200 μg/ml, or from about 10 μg/ml to about 125 μg/ml of a PEG-BDD-rFVIII;
- wherein said PEG-BDD-rFVIII formulation has a pH from about pH 6.0 to about pH 6.5, or about pH 7.0, or about pH 7.5.
A PEGylated B-domain deleted rFVIII-mutant (PEG BDD-rFVIII-mutant) formulation, comprising:
- a. from about 0 mM to about 20 mM or about 50 mM MOPS;
- b. from about 0 mM to about 29 mM, or about 34 mM, or about 58 mM, or about 100 mM, or about 300 mM of a sugar or sugar alcohol;
- c. from about 1 mM to about 2 mM, or about 2.5 mM, or about 5 mM, or about 10 mM, or about 15 mM calcium chloride;
- d. from about 100 mM to about 150 mM, or about 200 mM, or about 220 mM, or about 250 mM sodium chloride;
- e. from about 20 ppm to about 50 ppm, or about 80 ppm, or about 100 ppm, or about 120 ppm, or about 200 ppm of a non-ionic surfactant;
- and
- f. from about 0.1 μg/ml to about 300 μg/ml, or from about 1.0 μg/ml to about 200 μg/ml, or from about 10 μg/ml to about 125 μg/ml of a PEG BDD-rFVIII-mutant;
- wherein said PEG BDD-rFVIII-mutant formulation has a pH from about pH 6.0 to about pH 6.5, or about pH 7.0, or about pH 7.5.
A FL-rFVIII formulation, comprising:
- a. from about 0 mM to about 20 mM or about 50 mM histidine;
- b. from about 0 mM to about 29 mM, or about 34 mM, or about 58 mM, or about 100 mM, or about 300 mM of a sugar or sugar alcohol;
- c. from about 1 mM to about 2 mM, to about 2.5 mM, to about 5 mM calcium chloride;
- d. from about 0 mM to about 10 mM, or about 20 mM, or about 30 mM, or about 40 mM, or about 50 mM sodium chloride;
- e. from about 20 ppm to about 50 ppm, or about 80 ppm, or about 100 ppm, or about 120 ppm, or about 200 ppm of a non-ionic surfactant;
- f. from about 0 mM to about 50 mM, or about 100 mM, or about 150 mM, or about 293 mM, or about 400 mM glycine;
- and
- g. from about 0.1 μg/ml to about 300 μg/ml, or about 1.0 μg/ml to about 200 μg/ml, or about 10 μg/ml to about 125 μg/ml of a FL-rFVIII;
- wherein said FL-rFVIII formulation has a pH from about pH 6.0 to about pH 6.5, or about pH 7.0, or about pH 7.5.
A PEG-FL-rFVIII formulation, comprising:
- a. from about 0 mM to about 20 mM or about 50 mM histidine;
- b. from about 0 mM to about 29 mM, or about 34 mM, or about 58 mM, or about 100 mM, or about 300 mM of a sugar or sugar alcohol;
- c. from about 1 mM to about 2 mM, to about 2.5 mM, to about 5 mM calcium chloride;
- d. from about 0 mM to about 10 mM, or about 20 mM, or about 30 mM, or about 40 mM, or about 50 mM sodium chloride;
- e. from about 20 ppm to about 50 ppm, or about 80 ppm, or about 100 ppm, or about 120 ppm, or about 200 ppm of a non-ionic surfactant;
- f. from about 0 mM to about 50 mM, or about 100 mM, or about 150 mM, or about 293 mM, or about 400 mM glycine;
- and
- g. from about 0.1 μg/ml to about 300 μg/ml, or about 1.0 μg/ml to about 200 μg/ml, or about 10 μg/ml to about 125 μg/ml of a PEG-FL-rFVIII;
- wherein said PEG-FL-rFVIII formulation has a pH from about pH 6.0 to about pH 6.5, or about pH 7.0, or about pH 7.5.
A PEG-BDD-rFVIII formulation, comprising:
- a. from about 0 mM to about 20 mM or about 50 mM histidine;
- b. from about 0 mM to about 29 mM, or about 34 mM, or about 58 mM, or about 100 mM, or about 300 mM of a sugar or sugar alcohol;
- c. from about 1 mM to about 2 mM, to about 2.5 mM, to about 5 mM calcium chloride;
- d. from about 0 mM to about 10 mM, or about 20 mM, or about 30 mM, or about 40 mM, or about 50 mM sodium chloride;
- e. from about 20 ppm to about 50 ppm, or about 80 ppm, or about 100 ppm, or about 120 ppm, or about 200 ppm of a non-ionic surfactant;
- f. from about 0 mM to about 50 mM, or about 100 mM, or about 150 mM, or about 293 mM, or about 400 mM glycine;
- and
- g. from about 0.1 μg/ml to about 300 μg/ml, or about 1.0 μg/ml to about 200 μg/ml, or about 10 μg/ml to about 125 μg/ml of a PEG-BDD-rFVIII;
- wherein said PEG-BDD-rFVIII formulation has a pH from about pH 6.0 to about pH 6.5, or about pH 7.0, or about pH 7.5.
A PEG BDD-rFVIII-mutant formulation, comprising:
- a. from about 0 mM to about 20 mM or about 50 mM histidine;
- b. from about 0 mM to about 29 mM, or about 34 mM, or about 58 mM, or about 100 mM, or about 300 mM of a sugar or sugar alcohol;
- c. from about 1 mM to about 2 mM, to about 2.5 mM, to about 5 mM calcium chloride;
- d. from about 0 mM to about 10 mM, or about 20 mM, or about 30 mM, or about 40 mM, or about 50 mM sodium chloride;
- e. from about 20 ppm to about 50 ppm, or about 80 ppm, or about 100 ppm, or about 120 ppm, or about 200 ppm of a non-ionic surfactant;
- f. from about 0 mM to about 50 mM, or about 100 mM, or about 150 mM, or about 293 mM, or about 400 mM glycine;
- and
- g. from about 0.1 μg/ml to about 300 μg/ml, or about 1.0 μg/ml to about 200 μg/ml, or about 10 μg/ml to about 125 μg/ml of a PEG BDD-rFVIII-mutant;
- wherein said PEG BDD-rFVIII-mutant formulation has a pH from about pH 6.0 to about pH 6.5, or about pH 7.0, or about pH 7.5.
A FL-rFVIII formulation, comprising:
- a. from about 0 mM to about 20 mM or about 50 mM MOPS;
- b. from about 0 mM to about 29 mM, or about 34 mM, or about 58 mM, or about 100 mM, or about 300 mM of a sugar or sugar alcohol;
- c. from about 1 mM to about 2 mM, to about 2.5 mM, to about 5 mM calcium chloride;
- d. from about 0 mM to about 10 mM, or about 20 mM, or about 30 mM, or about 40 mM, or about 50 mM sodium chloride;
- e. from about 20 ppm to about 50 ppm, or about 80 ppm, or about 100 ppm, or about 120 ppm, or about 200 ppm of a non-ionic surfactant;
- f. from about 0 mM to about 50 mM, or about 100 mM, or about 150 mM, or about 293 mM, or about 400 mM glycine;
- and
- g. from about 0.1 μg/ml to about 300 μg/ml, or about 1.0 μg/ml to about 200 μg/ml, or about 10 μg/ml to about 125 μg/ml of a FL-rFVIII;
- wherein said FL-rFVIII formulation has a pH from about pH 6.0 to about pH 6.5, or about pH 7.0, or about pH 7.5.
A PEG-FL-rFVIII formulation, comprising:
- a. from about 0 mM to about 20 mM or about 50 mM MOPS;
- b. from about 0 mM to about 29 mM, or about 34 mM, or about 58 mM, or about 100 mM, or about 300 mM of a sugar or sugar alcohol;
- c. from about 1 mM to about 2 mM, to about 2.5 mM, to about 5 mM calcium chloride;
- d. from about 0 mM to about 10 mM, or about 20 mM, or about 30 mM, or about 40 mM, or about 50 mM sodium chloride;
- e. from about 20 ppm to about 50 ppm, or about 80 ppm, or about 100 ppm, or about 120 ppm, or about 200 ppm of a non-ionic surfactant;
- f. from about 0 mM to about 50 mM, or about 100 mM, or about 150 mM, or about 293 mM, or about 400 mM glycine;
- and
- g. from about 0.1 μg/ml to about 300 μg/ml, or about 1.0 μg/ml to about 200 μg/ml, or about 10 μg/ml to about 125 μg/ml of a PEG-FL-rFVIII;
- wherein said PEG-FL-rFVIII formulation has a pH from about pH 6.0 to about pH 6.5, or about pH 7.0, or about pH 7.5.
A PEG-BDD-rFVIII formulation, comprising:
- a. from about 0 mM to about 20 mM or about 50 mM MOPS;
- b. from about 0 mM to about 29 mM, or about 34 mM, or about 58 mM, or about 100 mM, or about 300 mM of a sugar or sugar alcohol;
- c. from about 1 mM to about 2 mM, to about 2.5 mM, to about 5 mM calcium chloride;
- d. from about 0 mM to about 10 mM, or about 20 mM, or about 30 mM, or about 40 mM, or about 50 mM sodium chloride;
- e. from about 20 ppm to about 50 ppm, or about 80 ppm, or about 100 ppm, or about 120 ppm, or about 200 ppm of a non-ionic surfactant;
- f. from about 0 mM to about 50 mM, or about 100 mM, or about 150 mM, or about 293 mM, or about 400 mM glycine;
- and
- g. from about 0.1 μg/ml to about 300 μg/ml, or about 1.0 μg/ml to about 200 μg/ml, or about 10 μg/ml to about 125 μg/ml of a PEG-BDD-rFVIII;
- wherein said PEG-BDD-rFVIII formulation has a pH from about pH 6.0 to about pH 6.5, or about pH 7.0, or about pH 7.5.
A PEG BDD-rFVIII-mutant formulation, comprising:
- a. from about 0 mM to about 20 mM or about 50 mM MOPS;
- b. from about 0 mM to about 29 mM, or about 34 mM, or about 58 mM, or about 100 mM, or about 300 mM of a sugar or sugar alcohol;
- c. from about 1 mM to about 2 mM, to about 2.5 mM, to about 5 mM calcium chloride;
- d. from about 0 mM to about 10 mM, or about 20 mM, or about 30 mM, or about 40 mM, or about 50 mM sodium chloride;
- e. from about 20 ppm to about 50 ppm, or about 80 ppm, or about 100 ppm, or about 120 ppm, or about 200 ppm of a non-ionic surfactant;
- f. from about 0 mM to about 50 mM, or about 100 mM, or about 150 mM, or about 293 mM, or about 400 mM glycine;
- and
- g. from about 0.1 μg/ml to about 300 μg/ml, or about 1.0 μg/ml to about 200 μg/ml, or about 10 μg/ml to about 125 μg/ml of a PEG BDD-rFVIII-mutant;
- wherein said PEG BDD-rFVIII-mutant formulation has a pH from about pH 6.0 to about pH 6.5, or about pH 7.0, or about pH 7.5.
Dependencies are inferred from the claim text.